No abstract available
Keywords:
ADHD; Adderall; Adhansia; Adzenys; Aptensio; Biphentin; Concerta; Cotempla; Daytrana; Dexedrine; Dyanavel; Evekeo; Focalin; Foquest; Intuniv; Jornay PM; Kapvay; Methylin; Monarch eTNS; Mydayis; ProCentra; QuilliChew; Ritalin; Strattera; Vyvanse; Zenzedi; adverse effects; amphetamines; atomoxetine; clonidine; dexmethylphenidate; dextroamphetamine; dosage; drug interactions; efficacy; guanfacine; lactation; lisdexamfetamine; methylphenidate; pregnancy; safety; stimulants.
MeSH terms
-
Adrenergic alpha-2 Receptor Agonists / administration & dosage
-
Adrenergic alpha-2 Receptor Agonists / adverse effects
-
Adrenergic alpha-2 Receptor Agonists / therapeutic use*
-
Amphetamines / administration & dosage
-
Amphetamines / adverse effects
-
Amphetamines / therapeutic use*
-
Attention Deficit Disorder with Hyperactivity / drug therapy*
-
Attention Deficit Disorder with Hyperactivity / psychology
-
Behavior Therapy
-
Central Nervous System Stimulants / administration & dosage
-
Central Nervous System Stimulants / adverse effects
-
Central Nervous System Stimulants / therapeutic use*
-
Child
-
Child, Preschool
-
Delayed-Action Preparations
-
Humans
-
Methylphenidate / administration & dosage
-
Methylphenidate / adverse effects
-
Methylphenidate / therapeutic use*
-
Transcutaneous Electric Nerve Stimulation
Substances
-
Adrenergic alpha-2 Receptor Agonists
-
Amphetamines
-
Central Nervous System Stimulants
-
Delayed-Action Preparations
-
Methylphenidate